A Study of Magnetic Resonance Elastography for Measuring Cancerous Tumor Response Following Treatment with Chemotherapy

Overview

About this study

The purpose of this study is to use magnetic resonance elastography to determine if the mechanical properties of either Hodgkin's or non-Hodgkin's lymphoma tumors change in response to the administration of chemotherapy agents (in which the agent is known to produce a positive treatment response) and that this change is detected by MRE within 24 hours following therapy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Adult
Male or female
Mayo Clinic patients undergoing chemotherapy treatment for either Hodgkin's or non-Hodgkin's lymphoma

Exclusion Criteria

Is or may become claustrophobic during the MR exam
Has medical device or implanted foreign metal object for which MR imaging is contraindicated

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Kiaran McGee, Ph.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Kiaran McGee, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials